Endothelin receptors in the aetiology and pathophysiology of varicose veins

European Journal of Vascular and Endovascular Surgery

Volumn 23, Issue 2, 2002, Pages 165-171

  Agu, O ^a   Hamilton, G ^a   Baker, D M ^a   Dashwood, M R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Endothelin; Varicose veins

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR;

ADULT; ANGIOGENESIS; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOGENESIS; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR BINDING; RECEPTOR DENSITY; SAPHENOUS VEIN; VARICOSIS; VENOCONSTRICTION; BINDING COMPETITION; COMPARATIVE STUDY; METABOLISM; MICROSCOPY; MIDDLE AGED; PHYSIOLOGY; STAINING; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

BINDING, COMPETITIVE; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ENDOTHELIN; STAINING AND LABELING; VARICOSE VEINS;

EID: 0036482243     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1569     Document Type: Article

References (36)

1. EVANS CJ, ALLAN PL, LEE AJ et al. Prevalence of venous reflux in the general population on duplex scanning: the Edinburgh vein study. J Vasc Surg 1998; 28: 767-776.
2. CALLAM MJ. Epidemiology of varicose veins. Br J Surg 1994; 81: 167-173.
3. GOLDMAN MP, WEISS RA, BERGAN JJ. Diagnosis and treatment of varicose veins. Dermatology 1994; 31: 393-413.
4. TRAVERS JP, BROOKES CE, EVANS J et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996; 11: 230-237.
5. ROSE SS, AHMED A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg (Torino) 1986; 27: 534-543.
6. KOCKX MM, KNAAPEN MW, BORTIEZ HE et al. Vascular remodeling in varicose veins. Angiology 1998; 49: 871-877.
7. PSAILA JV, MELHUISH J. Viscoelastic properties and collagen content of the long saphenous vein in normal and varicose veins. Br J Surg 1989; 76: 37-40.
8. NYAMEKYE I, SHEPHARD NA, DAVIES B, HEATHER BP, EARNSHAW JJ. Clinicopathological evidence that neovascularisation is a cause of recurrent varicose veins. Eur J Vasc Endovasc Surg 1998; 15: 412-415.
9. JONES L, BRAITHWAITE BD, SELWYN D, COOKE S, EARNSHAW JJ. Neovascularisation is the principal cause of varicose vein recurrence: results of a randomised trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg 1996; 12: 442-445.
10. WEBB DJ. Endogenous endothelin generation maintains vascular tone in humans. J Hum Hyperten 1995; 9: 459-463.
11. YANAGISAWA M, KURIHARA H, KIMURA S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
12. TAKUWA Y. Endothelin in vascular and endocrine systems: biological activities and its mechanisms of action. Endocrine J 1993; 40: 489-506.
13. LUSCHER TF, YANG Z, TSCHUDI M et al. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990; 66: 1088-1094.
14. LUSCHER TE Endothelium-derived vasoactive factors and regulation of vascular tone in human blood vessels. Lung 1990; 168 (Suppl. 27-34: 27-34.
15. BARBER DA, WANG X, GLOVICZKI P, MILLER VM. Characterization of endothelin receptors in human varicose veins. J Vasc Surg 1997; 26: 61-69.
16. DASHWOOD MR, TIMM M, MUDDLE JR et al. Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease. Endothelium 1998; 6: 61-70.
17. CORNU-THENARD A, BOIVIN P, BAUD JM, DE VI, CARPENTIER PH. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol 1994; 20: 318-326.
18. BERNI A, TROMBA L, MOSTI G et al. Recurrence of varicose veins after treatment. Multicenter study by the Italian Doppler Club, Clinical and Technological Society. Minerva Cardioangiologica 1998; 46: 87-90.
19. JONES L, BRAITHWAITE BD, SELWYN D, COOKE S, EARNSHAW JJ. Neovascularisation is the principal cause of varicose vein recurrence: results of a randomised trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg 1996; 12: 442-445.
20. LABROPOULOS N, TOULOUPAKIS E, GIANNOUKAS AD et al. Recurrent varicose veins: investigation of the pattern and extent of reflux with color flow duplex scanning. Surgery 1996; 119: 406-409.
21. RIZZI A, QUAGLIO D, VASQUEZ G et al. Effects of vasoactive agents in healthy and diseased human saphenous veins. J Vasc Surg 1998; 28: 855-861.
22. RUBANYI GM, POLOKOFF MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415.
23. SEO B, OEMAR BS, SIEBENMANN R, VON SEGESSER L, LUSCHER TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89: 1203-1208.
24. WHITE DG, GARRATT H, MUNDIN JW et al. Human saphenous vein contains both endothelin ETA and ETB contractile receptors. Eur J Pharmacol 1994; 257: 307-310.
25. BLOCHL-DAUM B, SCHULLER-PETROVIC S, WOLZT M et al. Primary defect in alpha-adrenergic responsiveness in patients with varicose veins. Clin Pharmacol Ther 1991; 49: 49-52.
26. BLALOCK A. The oxygen content of blood in varicose veins. Arch Surg 1929; 19: 898.
27. BLUMOFF RL, JOHNSON G. Saphenous vein pO2 in patients with varicose veins. J Surg Res 1977; 23: 35.
28. BARON HC, CASSARO S. The role of arteriovenous shunts in the pathogenesis of varicose veins. J Vasc Surg 1986; 4: 124-128.
29. REIKERAS O, SORLIE D. The significance of arteriovenous shunting for the development of varicose veins. Acta Chir Scand 1983; 149: 479-481.
30. SCOTT HJ, CHEATLE TR, MCMULLIN GM, COLERIDGE SMITH PD, SCURR JH. Reappraisal of the oxygenation of blood in varicose veins. Br J Surg 1990; 77: 934-936.
31. BARBER DA, MICHENER SR, ZIESMER SC, MILLER VM. Chronic increases in blood flow upregulate endothelin-B receptors in arterial smooth muscle. Am J Physiol 1996; 270: H65-H71.
32. MILLER VM, MICHENER SR. Modulation of contractions to and receptors for endothelins in canine veins. Am J Physiol 1995; 268: H345-H350.
33. CARLINI RG, DUSSO AS, OBIALO CI, ALVAREZ UM, ROTHSTEIN M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 1993; 43: 1010-1014.
34. PEDRAM A, RAZANDI M, HU RM, LEVIN ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 1997; 272: 17097-17103.
35. DAWAS K, LOIZIDOU M, SHANKAR A, ALI H, TAYLOR I. Angiogenesis in cancer: the role of endothelin-1. Ann R Coll Surg Engl 1999; 81: 306-310.
36. MORBIDELLI L, ORLANDO C, MAGGI CA, LEDDA F, ZICHE M. Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol 1995; 269: H686-H695.